Antirejection immunosuppressants: Nursing pharmacology
Introduction0:00–0:39
Antirejection immunosuppressants are medications used to prevent organ rejection after a transplant, which can occur when the recipient’s immune system attacks the transplanted organ.
These medications are also used to prevent graft-versus-host disease, or GvHD for short, which can occur after a bone marrow transplant.
GvHD is similar to transplant rejection but works the other way around, so it’s the donor or graft T cells that reject the recipient or host; and as a result, the recipient can develop life-threatening inflammation involving various organs.Now, based on their primary mechanism of action, antirejection immunosuppressants can be classified into several groups.
Immunosuppressants0:39–1:21
The first group covers inhibitors of transcription, and the main representatives here are cyclosporine and tacrolimus; the second group includes inhibitors of nucleotide synthesis, like mycophenolate; while the third group covers inhibitors of growth factor signal transduction, such as sirolimus.
Finally, the fourth group includes DNA alkylating agents, like cyclophosphamide. These medications are primarily administered orally or intravenously, and once administered, all immunosuppressants ultimately suppress and disrupt the inflammatory process and prevent the progression of the disease.Unfortunately, these medications can also increase the risk of side effects like myelosuppression; development of new infections; or reactivation of previous infections, such as hepatitis B.
Side effects1:21–2:07
Some immunosuppressants, like tacrolimus and mycophenolate, have a boxed warning for the development of certain cancers, especially lymphoma and skin cancer.
Other important side effects include hepatotoxicity, cardiotoxicity, as well as teratogenic effects. Some clients might experience vomiting, nausea, hyperglycemia, and menstrual irregularities, or may develop a skin rash, alopecia, and hypersensitivity reactions like anaphylaxis.
Lastly, cyclosporine has a boxed warning for systemic hypertension and nephrotoxicity.It’s important to note that immunosuppressants are contraindicated or have boxed warnings in individuals with active infections and lymphomas, as well as during pregnancy and breastfeeding.
Complications and cautions2:07–2:39
Another important contraindication is concomitant vaccine administration. Finally, these medications should be used with caution in clients with renal or hepatic impairment.
Tacrolimus and sirolimus have a boxed warning against use in infants and children, as well as in clients undergoing liver transplant.Now, when caring for a client who has had a kidney transplant and is prescribed cyclosporine as part of their antirejection regimen, first, perform a baseline assessment including weight and vital signs, especially blood pressure and temperature.
Nursing considerations & Client Education2:39–5:58
Also assess the transplant site, making note of any redness, swelling, or drainage; as well as other symptoms of rejection, which can include swelling of the hands and legs, decreased urine output, chills, nausea, and vomiting.
Lastly, review their most recent laboratory test results including CBC, renal and hepatic function tests; and confirm a negative pregnancy test as needed.
Okay, moving on to client education. Explain to your client that the medication helps prevent their immune system from attacking their kidney.
Encourage them to take their medication consistently with or without food, and at the same time each day. Teach your client to dispense the medication into a glass cup using the provided oral dosing syringe, mix the medication with a liquid like orange or apple juice, and to drink all of the liquid immediately.
To ensure they get the full dose, instruct them to pour a little more of the drink into the glass, swirl the glass around, and then drink the liquid.
Next, explain that the medication increases their risk for infection. Stress the importance of infection prevention measures in their daily routine, including frequent hand hygiene and avoiding large crowds, people with infections, undercooked meats, and live virus vaccines.
Remind your client that they should contact their healthcare provider if they experience any symptoms of a new infection including fever, rash, severe diarrhea, chills, sore throat, or fatigue.
In addition, let them know that their blood pressure may increase during therapy, and encourage them to follow up with their healthcare provider regularly for monitoring.
Now, if your client is a diabetic, advise them to check their blood glucose levels more often during treatment, and to monitor themselves for symptoms of hyperglycemia like increased thirst, hunger and urination.
Then, prompt them to immediately report symptoms of impaired renal function, which can present with decreased urine output, urinary hesitancy, or hematuria; hepatotoxicity, which could manifest as abdominal pain, nausea, vomiting, anorexia, dark-colored urine, or yellowing of the skin or eyes; as well as symptoms of transplant rejection, which can present as fever, decreased urine output, significant weight changes, and pain at the transplant site.
Lastly, caution your clients assigned female at birth, who are able to become pregnant, to use a reliable form of birth control while taking this medication, and to let their healthcare provider know right away if they become pregnant.
Finally, while your client is being treated with an immunosuppressant like cyclosporine, closely monitor or the development of side effects with routine checks of their vital signs, as well as renal and hepatic function.
Evaluate for the therapeutic effect of an absence of transplant rejection. All right, as a quick recap … Antirejection immunosuppressants are medications used to prevent rejection after organ transplant.
Review5:58–6:45
Immunosuppressants suppress and disrupt the inflammatory process and prevent rejection. Important side effects include myelosuppression, reactivation of infections like hepatitis B, development of new infections, hepatotoxicity, and cardiotoxicity and nephrotoxicity.
These medications can also increase the risk of developmenting certain cancers. When caring for a client taking an antirejection immunosuppressant, nursing considerations include performing a baseline assessment, monitoring for side effects, and evaluating the therapeutic effect.
Client teaching includes safe self-administration, recognition of potential side effects, and knowing when to contact the healthcare provider.
| ANTIREJECTION IMMUNOSUPPRESSANTS | ||||
| DRUG NAME | cyclosporine (Sandimmune, Gengraf, Neoral), tacrolimus (Astagraf XL) | mycophenolate (Cellcept, Myforic) | sirolimus (Rapamune) | cyclophosphamide |
| CLASS | Immunosuppressants | |||
| MECHANISM of ACTION | Inhibition of transcription | Inhibition of nucleotide synthesis | Inhibition of growth factor signal transduction | DNA alkylation |
| INDICATIONS | Prevention of organ transplant rejection and graft-versus-host disease (GvHD) | |||
| ROUTE(S) of ADMIN. | PO IV | |||
| SIDE EFFECTS |
| |||
| CONTRA-INDICATIONS |
| |||
| NURSING CONSIDERATIONS for ANTIREJECTION IMMUNOSUPPRESSANTS | ||
| ASSESSMENT AND MONITORING | Assessment and monitoring: cyclosporine Assessment
Monitoring
| |
| CLIENT EDUCATION |
| |
Author: Filip Vasiljević, MD
Illustrator: Elijah Lee, MScBMC
- "Karch’s Focus on Nursing Pharmacology, 9th edition" LWW (2023)
- "Pharmacology: A Patient-Centered Nursing Process Approach, 9th edition" Elsevier Canada (2020)
- "Mosby’s 2023 Nursing Drug Reference, 36th edition" Mosby (2022)
- "Saunders Comprehensive Review for the NCLEX-RN, 9th Edition" Saunders (2022)
- "Therapies for Chronic Allograft Rejection" Front Pharmacol (2021)
- "Properties of regulatory B cells regulating B cell targets" Am J Transplant (2021)
No notes for this video yet
Try adding a note below